The gut–brain axis and its relation to Parkinson's disease: a review

EM Klann, U Dissanayake, A Gurrala… - Frontiers in aging …, 2022 - frontiersin.org
Parkinson's disease is a chronic neurodegenerative disease characterized by the
accumulation of misfolded alpha-synuclein protein (Lewy bodies) in dopaminergic neurons …

Gut microbiota: a novel therapeutic target for Parkinson's disease

M Zhu, X Liu, Y Ye, X Yan, Y Cheng, L Zhao… - Frontiers in …, 2022 - frontiersin.org
Parkinson's disease (PD) is the second most common neurodegenerative disease
characterized by motor dysfunction. Growing evidence has demonstrated that gut dysbiosis …

The impact of nutrients on mental health and well-being: insights from the literature

M Muscaritoli - Frontiers in nutrition, 2021 - frontiersin.org
A good nutritional status is important for maintaining normal body function and preventing or
mitigating the dysfunction induced by internal or external factors. Nutritional deficiencies …

Neurogenic and anti-inflammatory effects of probiotics in Parkinson's disease: A systematic review of preclinical and clinical evidence

V Leta, KR Chaudhuri, O Milner, G Chung-Faye… - Brain, Behavior, and …, 2021 - Elsevier
There is increasing evidence highlighting the potential role of the gut-brain axis in the
pathogenesis of Parkinson's disease (PD) and on the use of probiotics as a therapeutic …

Psychobiotics for mitigation of neuro‐degenerative diseases: Recent advancements

P Dhyani, C Goyal, SB Dhull… - Molecular nutrition & …, 2024 - Wiley Online Library
Ageing is inevitable and poses a universal challenge for all living organisms, including
humans. The human body experiences rapid cell division and metabolism until …

Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease

C Cui, Y Han, H Li, H Yu, B Zhang, G Li - Frontiers in cellular and …, 2022 - frontiersin.org
Background Parkinson's disease (PD) is a common neurodegenerative disorder,
accompanied by motor deficits as well as gastrointestinal dysfunctions. Recent studies have …

Recent developments in the probiotics as live biotherapeutic products (LBPs) as modulators of gut brain axis related neurological conditions

D Ağagündüz, F Gençer Bingöl, E Çelik… - Journal of Translational …, 2022 - Springer
Probiotics have been defined as “living microorganisms that create health benefits in the
host when taken in sufficient amounts. Recent developments in the understanding of the …

Efficacy and safety of probiotics for the treatment of Alzheimer's disease, mild cognitive impairment, and Parkinson's disease: a systematic review and meta-analysis

S Xiang, JL Ji, S Li, XP Cao, W Xu, L Tan… - Frontiers in aging …, 2022 - frontiersin.org
Background Alzheimer's disease (AD) and Parkinson's disease (PD) are two of the most
common neurodegenerative diseases, and mild cognitive impairment (MCI) is considered a …

The interplay between gut microbiota and Parkinson's disease: Implications on diagnosis and treatment

A Varesi, LIM Campagnoli, F Fahmideh… - International journal of …, 2022 - mdpi.com
The bidirectional interaction between the gut microbiota (GM) and the Central Nervous
System, the so-called gut microbiota brain axis (GMBA), deeply affects brain function and …

Biotechnological applications of probiotics: a multifarious weapon to disease and metabolic abnormality

RP Singh, A Shadan, Y Ma - Probiotics and Antimicrobial Proteins, 2022 - Springer
Consumption of live microorganisms “Probiotics” for health benefits and well-being is
increasing worldwide. Their use as a therapeutic approach to confer health benefits has …